about
Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1alpha and is not induced by hypoxia or HIFHIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanismSphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cellsHypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species.Angiogenesis and G-protein-coupled receptors: signals that bridge the gap.Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferationThe prolyl isomerase Pin1 regulates hypoxia-inducible transcription factor (HIF) activity.Effects of TGF-beta1 on endothelial factors.Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression.(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors.Bovine adrenal glomerulosa cells express such a low level of functional B2 receptors that bradykinin does not significantly increase their aldosterone production.Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha.Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification.Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification.Selective HIF-1 Regulation under Nonhypoxic Conditions by the p42/p44 MAP Kinase Inhibitor PD184161.TGFbeta-induced GRK2 expression attenuates AngII-regulated vascular smooth muscle cell proliferation and migration.Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1.Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases.Novel cyclic analogs of angiotensin II with cyclization between positions 5 and 7: conformational and biological implicationsShort-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity stateStimulation of the angiotensin II type I receptor on bovine adrenal glomerulosa cells activates a temperature-sensitive internalization-recycling pathwayDesensitization of AT1 receptor-mediated cellular responses requires long term receptor down-regulation in bovine adrenal glomerulosa cellsInduction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanismsDifferential regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cellsThe Werner syndrome gene product (WRN): a repressor of hypoxia-inducible factor-1 activity
P50
Q28259619-9B1DCDBF-D64C-45B2-AFC2-7EA00AC3F0F9Q28583933-3219AD07-FADF-4C7C-BB5B-BCDB8B639A92Q28584072-E96E22DA-9327-4712-9290-72A7727D3024Q34123420-A87263F8-913A-456C-86EA-868A9D7D6659Q34225966-E1ADCCBF-040A-4DDB-890F-B0916E9CB140Q34238582-BD4491BF-5186-424C-9FDE-8FDF5D7C2052Q39004846-88597163-5259-4557-83BA-2150FE3D39B7Q39742093-F09F3A77-5C79-441B-8357-65A99159497BQ40260497-C7606094-729F-495F-A343-3771569A8BAAQ42082584-5F0D5633-9AE0-4B00-9824-EEFB1A0919AEQ42455024-8166054A-EF99-4315-9585-20AE96E2E3C3Q44606435-8FEB31CF-D518-4827-BA8B-0C90083ED65FQ46241430-BA2A445D-5A18-40EE-9865-265C83190C5AQ46809557-9B19F05E-C205-4AD6-9909-19D04917F8EDQ47944380-E8E1A780-910D-4598-B656-4350538C1B7DQ47964492-7FE32296-62AC-49B3-9A96-A53B54C2008EQ51242487-DAA321CD-4C2B-4457-B588-4036AA8C2014Q52173333-AB24034E-8252-4611-8489-A2577A0D63B1Q54656142-BBF828C6-AF9B-40F2-A82C-45FD89484E52Q71262753-114349A4-3BF4-412A-94D4-71A3FDF67734Q72796279-E4D9F3B2-71FD-4CE2-A1E7-82423BA22423Q73457081-0141A453-B456-48F6-A662-F42FFEB40EA7Q73635412-2A406F73-6D85-40F9-9AA8-83D7CCC22700Q78371716-AB526166-50CC-47FD-9158-76759C9FF486Q80351950-31A1392E-0A48-41F4-9ACA-7918DC46221CQ84279172-F645BCD8-C42B-4B0E-A466-4CC04CE6CB60
P50
description
chercheur et professeur d'université
@fr
researcher and university professor
@en
wetenschapper
@nl
հետազոտող
@hy
name
Darren E. Richard
@ast
Darren E. Richard
@en
Darren E. Richard
@es
Darren E. Richard
@fr
Darren E. Richard
@nl
Darren E. Richard
@sl
type
label
Darren E. Richard
@ast
Darren E. Richard
@en
Darren E. Richard
@es
Darren E. Richard
@fr
Darren E. Richard
@nl
Darren E. Richard
@sl
altLabel
Darren Edward Richard
@en
Darren Edward Richard
@es
Darren Edward Richard
@fr
Darren Richard
@en
Darren Richard
@es
Darren Richard
@fr
prefLabel
Darren E. Richard
@ast
Darren E. Richard
@en
Darren E. Richard
@es
Darren E. Richard
@fr
Darren E. Richard
@nl
Darren E. Richard
@sl
P214
P108
P1153
7102203342
P21
P213
0000 0000 7662 3352
P214
P31
P496
0000-0003-2690-0480
P569
1969-01-01T00:00:00Z
P6634
darren-richard-97878338
P734
P735
P7859
viaf-105778161